Skip Navigation
Department of Health and Human Services www.hhs.gov
  • CME/CE Activities
  • Guidance for Diagnostic Tools and Treatments for Obstructive Sleep Apnea
 
This website is iPhone friendly.

This CME/CE activity is provided by PRIME Education, Inc. (PRIME®) and is accredited for a multi-disciplinary audience of health care practitioners. This activity is supported by contract number HHSA290201200021I from the Agency for Healthcare Research and Quality. User data collected through this activity will reside on PRIME's educational portal for use by AHRQ.

Guidance for Informed and Shared Decision Making about Diagnostic Tools and Treatments for Obstructive Sleep Apnea

To Receive a Certificate for This Activity:

Course Image
  1. 1. Read the Program Overview on this page.
  2. 2. Review the Faculty Biographies, Accreditation Statements, and Disclosure tabs.
  3. 3. Access the Activity in full.
  4. 4. Complete the Post-Test & Evaluation.
  5. 5. A printable certificate will be available immediately following the activity.

Program Overview

Activity Description

Obstructive sleep apnea (OSA) is a common disorder of repeated collapse and obstruction of the upper airway during sleep. Affected individuals may experience reduced airflow (hypopnea) or complete airflow cessation (apnea), oxygen desaturation, and arousals from sleep. A number of serious adverse clinical outcomes are associated with OSA, including cardiovascular disease, hypertension, and type 2 diabetes mellitus. In clinical settings, OSA has been characterized by uncertainty regarding optimal criteria and instruments for screening and diagnosis; in addition, ongoing debates center on appropriate treatments for the condition. In July 2011, the Agency for Healthcare Research and Quality (AHRQ) published a comparative effectiveness review of diagnostic instruments and treatments for OSA in adults. The review indicated that (1) portable monitors and questionnaires may be effective screening tools; (2) continuous positive airway pressure (CPAP) is highly effective in improving clinical outcomes; (3) oral devices are also effective, although not as effective as CPAP; and (4) other interventions, including those to improve patient adherence, have not been adequately tested.

This video guides clinicians through best practices in talking with patients about their options for diagnostic methods and treatments for OSA. The program highlights how to apply the findings from the AHRQ comparative effectiveness review in informed and shared decision making. This summary is intended to provide evidence to guide clinicians, health care payers, and policy makers in reaching decisions about effective methods for screening, diagnosing, and treating patients with OSA.

Core Competencies:

  • Patient Care
  • Interpersonal Skills and Communication
  • Medical Knowledge

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Summarize evidence on the comparative utility of available tests for diagnosing sleep apnea in adults with symptoms suggestive of disordered sleep
  • Compare the benefits and risks of various surgical, pharmacological, and nonpharmacological treatments for obstructive sleep apnea
  • Apply relevant findings from the review to making shared and informed diagnostic and treatment decisions and to helping patients adhere to appropriate therapy regimens

Target Audience

This CME activity is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, pharmacists, nurses, case managers, health educators and medical assistants.

Method of Participation

To receive a certificate for this activity, you should:

  • Complete the learner assessment pretest
  • View the entire activity online (Hardware/Software Requirements: Broadband & Flash Player or HTML5 browser)
  • Complete an online evaluation & post-test
  • Print your certificate online

The estimated time to complete this activity, including review of the materials, is 1.0 hour.

Term of Approval

October 15, 2013 through October 14, 2014. Original release date: October 31, 2011.

Acknowledgement of Support

There is no fee for this CME/CE activity. This activity is sponsored by PRIME Education, Inc (PRIME®) and funded under contract HHSA290201200021I from the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services (HHS).

Faculty Biographies and Disclosures

Click faculty name to view full biography.

Speaker

Carolyn D'Ambrosio, MD
Director, The Center for Sleep Medicine
Tufts Medical Center
Associate Professor of Medicine
Pulmonary, Critical Care and Sleep Medicine Division
Tufts University School of Medicine
Boston MA

Planner

Carolyn LePage, PhD, ARNP
Assistant Professor
Barry University School of Nursing
Miami Shores, FL

Planner

Heidi Wynn Maloni, PhD, ANP-BC, CNRN, MSCN
National Clinical Nursing Director
Department of Neurology
Multiple Sclerosis Center of Excellence, East
Veterans Affairs Medical Center
Adjunct Faculty
Trinity Nursing Program School of Professional Studies
Trinity Washington University
Clinical Preceptor and Instructor
Advanced Practice Programs
The Catholic University of America School of Nursing
Washington, DC

Planner

Michele B Kaufman, PharmD, CGP, RPh
President, PRN Communications Inc.
Editor, Pharmacovigilance Forum, P&T Journal
NYCSHP Secretary
Adjunct Faculty
Touro College of Pharmacy
New York, NY

Planner

Wanda F Carter, MPH, CHES
Adjunct Professor, Kaplan University Master of Public Health Program
Adjunct Professor, Axia College (U of Phoenix) Health Care Administration Program
Adjunct Professor, LA College International Health Care Administration Program
Adjunct Professor, Ashford University Health Care Administration Program
PHPS Alumnus, CDC Scientific Education and Professional Development Program Office

Peer Reviewer

Donna M Chiefari, BSc (Pharm), PharmD, RPh, FASHP
Adjunct Faculty & Preceptor
Albany College of Pharmacy
Albany, NY

Peer Reviewer

Joyce M Knestrick, PhD, CRNP, FAANP
Coordinator of Graduate Education
Frontier School of Midwifery and Family Nursing
Certified Family Nurse Practitioner
The Primary Care Center
Mt Morris, PA

Peer Reviewer

Kathleen A Jarvis, MS, RN, CCM
Clinical Educator
Alere Healthcare
Fort Lauderdale, FL

Peer Reviewer

Michael N Baxley, MD, MS, MPH
Chief of Quality Medical Initiative
MCCI Medical Group
Miami, FL
President and Founder Physician
AUK DOK
Managed Care Consulting Service Company
Miami, FL

Begin Activity

Accreditation/Credit Designation

Physician Credit Designation Statement

A C C M E Logo

In support of improving patient care, PRIME Education, Inc. (PRIME®) is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

PRIME® designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistant Accreditation Statement

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Physician assistants may receive a maximum of 1.0 hours of Category I credit for completing this program.

Nurse Practitioner Accreditation Statement

Nurse Practitioner Logo

PRIME Education, Inc (PRIME®) is approved as a provider of Nurse Practitioner Continuing Education by the American Association of Nurse Practitioners. Provider number: 060815. This program is accredited for 1.0 contact hour. Program ID# CER16.

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

Pharmacist Accreditation StatementA C P E Logo

In support of improving patient care, PRIME Education, Inc. (PRIME®) is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

This curriculum has been approved for 1.0 contact hour (0.1 CEUs) by PRIME®. The Universal Activity Number for this program is 0255-0000-13-029-H01-P. This learning activity is Knowledge-Based.

Nurse Accreditation StatementA N C C Logo

In support of improving patient care, PRIME Education, Inc. (PRIME®) is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

PRIME® designates this activity for 1.0 contact hour.

Medical Assistant Accreditation Statement

This program has been granted prior approval by the American Association of Medical Assistants (AAMA) for 1.0 Continuing Education unit. Approval #125192. Granting approval in no way constitutes endorsement by the AAMA of the program content or the program's sponsor.

Begin Activity

Faculty Disclosures

Faculty Name
Advisory Board Consultant Grants / Research Salary / Contractual Supported Promotional Education Stock / Shareholder Other Financial Support
Carolyn D'Ambrosio, MD
Speaker
None None None None None None None
Carolyn LePage, PhD, ARNP
Planner
None None None Barry University None None None
Heidi Wynn Maloni, PhD, ANP-BC, CNRN, MSCN
Planner
sanofi-aventis None None None None None None
Michele B Kaufman, PharmD, CGP, RPh
Planner
None None None None None None None
Wanda F Carter, MPH, CHES
Planner
None None None None None None None
Donna M Chiefari, BSc (Pharm), PharmD, RPh, FASHP
Reviewer
None None None None None None None
Joyce M Knestrick, PhD, CRNP, FAANP
Reviewer
None None None None None None None
Kathleen A Jarvis, MS, RN, CCM
Reviewer
None None None None None None None
Michael N Baxley, MD, MS, MPH
Reviewer
None None None None None None None
Chris R Prostko, PhD
Scientific Program Director
NoneNoneNonePRIME®NoneNoneNone
Lynn Goldenberg, RN, BSN
Director of Accreditation & Compliance
NoneNoneNonePRIME®NoneNoneNone

Disclosure Policy

PRIME Education Inc (PRIME®) endorses the standards of the ACCME, as well as those of the AANP, ANCC and ACPE, that require everyone in a position to control the content of a CME/CE activity to disclose all financial relationships with commercial interests that are related to the content of the CME/CE activity. CME/CE activities must be balanced, independent of commercial bias and promote improvements or quality in healthcare. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

A conflict of interest is created when individuals in a position to control the content of CME/CE have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.

PRIME® willidentify, review and resolve all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for speakers, authors, course directors, planners, peer reviewers, and/or relevant staff are provided with this activity.

Presentations that provide information in whole or in part related to non FDA approved uses of drugs and/or devices will disclose the unlabeled indications or the investigational nature of their proposed uses to the audience. Participants should refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Participants should verify all information and data before treating patients or employing any therapies prescribed in this educational activity. The opinions expressed in the educational activity are those of the presenting faculty and do not necessarily represent the views of PRIME®, the ACCME, AANP, ACPE, ANCC and other relevant accreditation bodies.

Content validation methods are consistently utilized by PRIME® to ensure that all program content is evidence-based, fair-balanced, and developed with scientific rigor and integrity. All clinical recommendations are based on evidence accepted within the medical profession. All scientific research referred to, reported or used to support a clinical recommendation conforms to accepted standards of experimental design, data collection and analysis. In addition to review of content by course directors and expert faculty, content is also validated through independent peer reviewers selected for their expertise in the content area, as well as their experience in the intended audience. All peer reviewers, planners, course directors, faculty and relevant staff utilized by PRIME® complete disclosures which are related to their role in the educational activity.

Accessibility

PRIME®is committed to providing access to our CME programs for individuals with disabilities as identified in Section 508 of the Rehabilitation Act for all web-based programs. This website is 508 compliant.

Begin Activity

Pretest

To access the activity, please complete this brief Pretest.

  • Returning user? Login Here!
  1. Before accessing this educational activity, were you aware of the AHRQ-supported comparative effectiveness research on obstructive sleep apnea?

  2. How would you describe your current level of confidence in applying comparative effectiveness research on obstructive sleep apnea?

  3. How valuable is comparative effectiveness research on obstructive sleep apnea in making patient-centered treatment and management decisions?

  4. Which of the following comorbidities and risks are associated with obstructive sleep apnea?

  5. Which of the following measures indicates that a patient with OSA is at greatest risk for adverse outcomes?

  6. If you had a clinician guide/consumer guide on obstructive sleep apnea, what would you most likely do?

  7. PG, a 53-year-old obese man with hypertension, visited his primary care office after his wife observed that he was not breathing normally during sleep. PG’s physician recommended a facility-based polysomnography study, which confirmed a diagnosis of obstructive sleep apnea (OSA). PG began OSA treatment with fixed continuous positive airway pressure (CPAP). Which of the following factors are most appropriate to consider when prescribing CPAP as initial therapy for OSA?

Post-Test & Evaluation

You must access the activity before receiving credit!

Clinician & Consumer Summaries on Sleep Apnea

Download these free summaries for your reference and/or patient handouts. You may also order bulk copies free of charge from the AHRQ Publication Clearinghouse below.

AHRQ Clearinghouse Bulk Order Form

Returning user? Login Here
  • (Limit 200)
  • (This answer helps stop spam )
  • Alternatively, you can call the AHRQ Publications Clearinghouse at 1-800-358-9295. Reference the title and product number above.